Fundamental analysis by Golden Goal🎖 about Stock دزهراوی on 7/10/2024

#Dezravi informs respected shareholders. The price of a number of products of the company has been modified by the Food and Drug Administration due to the increase in the cost of the products, which increased the annual sales of these products by an average of 8%. According to the planning of the production of some of these products this month, it attracts the attention of respected shareholders to the above. In the event of significant changes to the sales rate of the product in the coming months, the necessary information was made. Zahravi Pharmaceutical Company